vs
科睿唯安（CLVT）与Concentra Group Holdings Parent, Inc.（CON）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是Concentra Group Holdings Parent, Inc.的1.1倍（$585.5M vs $539.1M），Concentra Group Holdings Parent, Inc.净利率更高（6.4% vs -6.9%，领先13.3%），Concentra Group Holdings Parent, Inc.自由现金流更多（$98.5M vs $78.9M）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Concentra是美国的职业医疗服务商，1979年成立于得克萨斯州阿马里洛，总部位于得克萨斯州艾迪生。业务覆盖美国47个州，运营627家职业医疗中心和410个雇主驻地现场诊所，美国每7起职业伤害案例中就有1起由该机构提供诊疗服务。
CLVT vs CON — 直观对比
营收规模更大
CLVT
是对方的1.1倍
$539.1M
净利率更高
CON
高出13.3%
-6.9%
自由现金流更多
CON
多$19.6M
$78.9M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $539.1M |
| 净利润 | $-40.2M | $34.7M |
| 毛利率 | 67.2% | — |
| 营业利润率 | 5.2% | 12.9% |
| 净利率 | -6.9% | 6.4% |
| 营收同比 | -1.4% | — |
| 净利润同比 | 61.3% | — |
| 每股收益（稀释后） | $-0.06 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTCON
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $539.1M | ||
| Q3 25 | $623.1M | $572.8M | ||
| Q2 25 | $621.4M | $550.8M | ||
| Q1 25 | $593.7M | $500.8M | ||
| Q4 24 | $663.0M | — | ||
| Q3 24 | $622.2M | $489.6M | ||
| Q2 24 | $650.3M | $477.9M |
净利润CLVTCON
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $34.7M | ||
| Q3 25 | $-28.3M | $48.3M | ||
| Q2 25 | $-72.0M | $44.6M | ||
| Q1 25 | $-103.9M | $38.9M | ||
| Q4 24 | $-191.8M | — | ||
| Q3 24 | $-65.6M | $44.3M | ||
| Q2 24 | $-304.3M | $51.7M |
毛利率CLVTCON
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | — | ||
| Q3 24 | 66.2% | — | ||
| Q2 24 | 67.2% | — |
营业利润率CLVTCON
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | 12.9% | ||
| Q3 25 | 7.1% | 16.5% | ||
| Q2 25 | 1.1% | 16.3% | ||
| Q1 25 | -3.5% | 16.0% | ||
| Q4 24 | -9.4% | — | ||
| Q3 24 | 3.5% | 17.6% | ||
| Q2 24 | -36.9% | 17.6% |
净利率CLVTCON
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | 6.4% | ||
| Q3 25 | -4.5% | 8.4% | ||
| Q2 25 | -11.6% | 8.1% | ||
| Q1 25 | -17.5% | 7.8% | ||
| Q4 24 | -28.9% | — | ||
| Q3 24 | -10.5% | 9.1% | ||
| Q2 24 | -46.8% | 10.8% |
每股收益（稀释后）CLVTCON
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | $0.27 | ||
| Q3 25 | $-0.04 | $0.38 | ||
| Q2 25 | $-0.11 | $0.35 | ||
| Q1 25 | $-0.15 | $0.30 | ||
| Q4 24 | $-0.27 | — | ||
| Q3 24 | $-0.09 | $0.37 | ||
| Q2 24 | $-0.46 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $79.9M |
| 总债务越低越好 | $4.3B | $1.6B |
| 股东权益账面价值 | $4.8B | $393.3M |
| 总资产 | $10.9B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.89× | 3.98× |
8季度趋势，按日历期对齐
现金及短期投资CLVTCON
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | $79.9M | ||
| Q3 25 | $318.7M | $49.9M | ||
| Q2 25 | $362.6M | $73.9M | ||
| Q1 25 | $354.0M | $52.1M | ||
| Q4 24 | $295.2M | — | ||
| Q3 24 | $388.5M | $136.8M | ||
| Q2 24 | $376.4M | $50.7M |
总债务CLVTCON
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $1.6B | ||
| Q3 25 | $4.4B | $1.6B | ||
| Q2 25 | $4.5B | $1.7B | ||
| Q1 25 | $4.5B | $1.6B | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.6B | $1.5B | ||
| Q2 24 | $4.6B | $3.0M |
股东权益CLVTCON
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $393.3M | ||
| Q3 25 | $4.9B | $385.5M | ||
| Q2 25 | $5.0B | $342.6M | ||
| Q1 25 | $5.0B | $307.1M | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | $5.5B | $277.8M | ||
| Q2 24 | $5.6B | $1.2B |
总资产CLVTCON
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $2.9B | ||
| Q3 25 | $11.2B | $2.8B | ||
| Q2 25 | $11.4B | $2.8B | ||
| Q1 25 | $11.5B | $2.7B | ||
| Q4 24 | $11.5B | — | ||
| Q3 24 | $12.0B | $2.5B | ||
| Q2 24 | $12.1B | $2.4B |
负债/权益比CLVTCON
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | 3.98× | ||
| Q3 25 | 0.90× | 4.15× | ||
| Q2 25 | 0.90× | 4.82× | ||
| Q1 25 | 0.90× | 5.27× | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | 5.30× | ||
| Q2 24 | 0.83× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $118.7M |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $98.5M |
| 自由现金流率自由现金流/营收 | 13.5% | 18.3% |
| 资本支出强度资本支出/营收 | 9.5% | 3.7% |
| 现金转化率经营现金流/净利润 | — | 3.42× |
| 过去12个月自由现金流最近4个季度 | $333.9M | $197.1M |
8季度趋势，按日历期对齐
经营现金流CLVTCON
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $118.7M | ||
| Q3 25 | $181.1M | $60.6M | ||
| Q2 25 | $116.3M | $88.4M | ||
| Q1 25 | $171.2M | $11.7M | ||
| Q4 24 | $141.3M | — | ||
| Q3 24 | $202.9M | $65.9M | ||
| Q2 24 | $126.2M | — |
自由现金流CLVTCON
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $98.5M | ||
| Q3 25 | $115.5M | $39.4M | ||
| Q2 25 | $50.3M | $63.2M | ||
| Q1 25 | $110.3M | $-4.0M | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $126.3M | $50.8M | ||
| Q2 24 | $60.3M | — |
自由现金流率CLVTCON
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | 18.3% | ||
| Q3 25 | 18.5% | 6.9% | ||
| Q2 25 | 8.1% | 11.5% | ||
| Q1 25 | 18.6% | -0.8% | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 20.3% | 10.4% | ||
| Q2 24 | 9.3% | — |
资本支出强度CLVTCON
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 3.7% | ||
| Q3 25 | 10.5% | 3.7% | ||
| Q2 25 | 10.6% | 4.6% | ||
| Q1 25 | 10.3% | 3.1% | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 12.3% | 3.1% | ||
| Q2 24 | 10.1% | — |
现金转化率CLVTCON
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 3.42× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.98× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
CON
| Occupational Health Center Workers Compensation | $328.5M | 61% |
| Occupational Health Center Employer Services | $151.9M | 28% |
| Onsite Health Clinics | $36.2M | 7% |
| Other Businesses | $12.3M | 2% |
| Occupational Health Center Consumer Health | $8.1M | 2% |
| Occupational Health Center Other | $2.1M | 0% |
